Cerevel Therapeutics to be Acquired by AbbVie for $8.7 Billion NewsbysupervisorDecember 6, 20231 minute readNo comments
Concerns about the 2024 GOP Presidential Nomination NewsbysupervisorDecember 6, 20232 minute readNo comments
News U.S. FTC Dismisses Action Against Axon Following Supreme Court Ruling The U.S. Federal Trade Commission (FTC) has announced the dismissal of its administrative action against Axon Enterprise, a… supervisorOctober 9, 2023 Read More
